Understanding Immunotherapy Options for Adult ALL
Immunotherapy is playing an increasingly important role in the treatment of ALL. In this session, we’ll talk about how it works today, what options are available, and what new approaches are under investigation. Dr. Chen, an adult leukemia specialist with expertise in immunotherapy and clinical research, will guide us through these topics and share what they mean for patients and families.
Marilu introduces the agenda of the event and our guest speaker Dr Evan C. Chen
Dr. Chen discusses immunotherapy options for adult ALL patients
Type your questions in the chat and we will answer them!
Marilú Nájera Flores
Marilu Najera is an International Medical Graduate and an Event Operations Manager at the HealthTree Foundation. Her journey through several patient-centered roles has deepened her passion for advocacy, education, and connection. Now, as part of the education team, she is leading efforts to grow HealthTree’s newest community: ALL (acute lymphoblastic leukemia). She organizes patient-friendly webinars with expert speakers and works to ensure that patients and families feel informed, empowered, and supported. Marilu brings empathy, joy, and warmth to every project. Outside of work, she loves to travel, connect with others, and spend time with her loved ones—especially her nephews (being an aunt is her absolute favorite role in life!).
Dr. Evan C. Chen
Dr. Evan C. Chen is an Attending Physician in the Adult Leukemia Program at the Dana-Farber Cancer Institute, and an Instructor in Medicine at Harvard Medical School. He is a clinician and clinical investigator who cares for patients with myeloid malignancies and acute leukemias, including acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms. His research interests are in the development of new therapies for myeloid malignancies, with a focus on cellular therapy strategies and the study of leukemia epigenetics.